stockrowEvolus, Inc. (EOLS) vs Kamada Ltd. (KMDA)
- Evolus, Inc. EOLS 6.86 −8.17%
- Kamada Ltd. KMDA 6.89 −7.14%
Evolus, Inc. and Kamada Ltd. are both Drug Manufacturers Specialty & Generic companies. Evolus, Inc. is the larger, with a market value of $448.8M against $396.3M — 1.1× the size. Evolus, Inc. has negative trailing earnings, so its P/E is not meaningful; Kamada Ltd. trades at 18.1×. Evolus, Inc. grew revenue faster over the last twelve months: 13.9% against 13.2%. Kamada Ltd. has the higher net margin (11.6% vs −9.56%) and the higher return on invested capital (8.47% vs −12.6%). Across the 18 metrics below, Kamada Ltd. leads on 11 and Evolus, Inc. on 7.
Valuation
Profitability
| Metric | EOLS | KMDA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 66.38% | 40.82% | 53.51% |
| Operating margin | (4.79%) | 14.51% | 0.00% |
| Net margin | (9.56%) | 11.60% | (2.45%) |
| Free cash flow margin | (2.71%) | 13.72% | 0.00% |
| Return on equity | 93.47% | 8.40% | (0.80%) |
| Return on assets | (12.38%) | 5.92% | (1.67%) |
| Return on invested capital | (12.60%) | 8.47% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack